Propanc Biopharma extends $177,980 note maturity to Sept 30, 2024

Propanc Biopharma, Inc.

Maturity of 10% OID Promissory Note with Ionic Ventures extended from Nov 15, 2023 to Sept 30, 2024.
Current principal amount $177,980; original principal $132,000.
Parties agree no event of default solely due to late payment of principal and interest.
All other terms of the Note remain in full force and effect.

item 1.01 item 2.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Propanc Biopharma, Inc. entered into Maturity Extension Agreement with Ionic Ventures, LLC (effective 2024-05-10).

Action: entry
Counterparty: Ionic Ventures, LLC
Effective: 2024-05-10

Exact text from the filing

On May 10, 2024, Propanc Biopharma, Inc. (the “Company”) entered into a Maturity Extension Agreement (the “Extension Agreement”) with Ionic Ventures, LLC (the “Ionic”), pursuant to which the Ionic agreed to extend the maturity date of original 10% OID Promissory Note issued on August 15, 2023 (the “Original Note”) to September 30, 2024.

View on SEC.gov

Browse all material agreements →

Propanc Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-020101

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.